(Q36118566)

12 August 2017

title

Adolescence, schizophrenia and drug abuse: a window of vulnerability (English)

1 reference

12 August 2017

0 references

1 reference

1 reference

L van Nimwegen

1

1 reference

12 August 2017

L de Haan

2

1 reference

12 August 2017

N van Beveren

3

1 reference

12 August 2017

W van den Brink

4

1 reference

12 August 2017

D Linszen

5

1 reference

12 August 2017

publication date

1 January 2005

1 reference

Acta psychiatrica Scandinavica. Supplementum

12 August 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

12 August 2017

issue

427

1 reference

12 August 2017

page(s)

35-42

1 reference

A neurobiological basis for substance abuse comorbidity in schizophrenia

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Patterns of current and lifetime substance use in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Glutamate receptor dysfunction and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

From neuropathology to neurodevelopment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Neural development, cell-cell signaling, and the "two-hit" hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Continuity, stability, and change in daily emotional experience across adolescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Schizophrenia-an evolutionary enigma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

A candidate molecule approach to defining developmental pathology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Modifiable neuronal connections: an overview for psychiatrists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Schizophrenia as a disorder of developmentally reduced synaptic connectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Synaptic elimination, neurodevelopment, and the mechanism of hallucinated "voices" in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Implications of normal brain development for the pathogenesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Early-onset drug use and risk of later drug problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Patterns of initiation of sex and drug-related activities among urban low-income African-American adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Cannabinoid transmission and reward-related events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Limbic activation during cue-induced cocaine craving

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

The effects of cannabinoids on the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Causal association between cannabis and psychosis: examination of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Cannabis and schizophrenia: results of a follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Dual diagnosis: a review of etiological theories

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Relapse of paranoid psychotic state in methamphetamine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00543.X

10.1111/J.1600-0447.2005.00543.X

21 January 2018

Identifiers

DOI

0 references

1 reference